Skip to main content
Erschienen in: Neurological Sciences 1/2012

01.05.2012 | A REDEFINITION OF PRIMARY HEADACHES

Sinus venous stenosis, intracranial hypertension and progression of primary headaches

verfasst von: Roberto De Simone, Angelo Ranieri, Silvana Montella, Mario Marchese, Pasquale Persico, Vincenzo Bonavita

Erschienen in: Neurological Sciences | Sonderheft 1/2012

Einloggen, um Zugang zu erhalten

Abstract

The recently advanced hypothesis that idiopathic intracranial hypertension without papilledema (IIHWOP) is a powerful risk factor for the progression of pain in individuals prone to episodic primary headache implies that IIHWOP is much more prevalent than it is believed to be in the general population and that it can run almost asymptomatic in most of the affected individuals. In this review, we discuss the evidence available supporting that: (a) sinus venous stenosis-associated IIHWOP is much more prevalent than believed in the general population and can run without symptoms or signs of raised intracranial pressure in most of individuals affected, (b) sinus venous stenosis is a very sensitive and specific predictor of intermittent or continuous idiopathic intracranial hypertension with or without papilledema, even in asymptomatic individuals, (c) in primary headache prone individuals, a comorbidity with a hidden stenosis-associated IIHWOP represents a very common, although largely underestimated, modifiable risk factor for the progression and refractoriness of headache.
Literatur
1.
Zurück zum Zitat Scher AI, Stewart WF, Liberman J et al (1998) Prevalence of frequent headache in a population sample. Headache 38:497–506PubMedCrossRef Scher AI, Stewart WF, Liberman J et al (1998) Prevalence of frequent headache in a population sample. Headache 38:497–506PubMedCrossRef
2.
Zurück zum Zitat Castillo J, Muñoz P, Guitera V et al (1998) Kaplan Award 1998: Epidemiology of chronic daily headache in the general population. Headache 39:190–196CrossRef Castillo J, Muñoz P, Guitera V et al (1998) Kaplan Award 1998: Epidemiology of chronic daily headache in the general population. Headache 39:190–196CrossRef
3.
Zurück zum Zitat Bigal ME, Lipton RB (2006) Obesity is a risk-factor for transformed migraine but not chronic tension-type headache. Neurology 67:252–257PubMedCrossRef Bigal ME, Lipton RB (2006) Obesity is a risk-factor for transformed migraine but not chronic tension-type headache. Neurology 67:252–257PubMedCrossRef
4.
Zurück zum Zitat Leonardi M, Steiner TJ, Scher AT et al (2005) The global burden of migraine: measuring disability in headache disorders with WHO’s classification of Functioning, Disability and Health (ICF). J Headache Pain 6:429–440PubMedCrossRef Leonardi M, Steiner TJ, Scher AT et al (2005) The global burden of migraine: measuring disability in headache disorders with WHO’s classification of Functioning, Disability and Health (ICF). J Headache Pain 6:429–440PubMedCrossRef
5.
Zurück zum Zitat Edmeads J, Mackell JA (2002) The economic impact of migraine: an analysis of direct and indirect costs. Headache 42:501–509PubMedCrossRef Edmeads J, Mackell JA (2002) The economic impact of migraine: an analysis of direct and indirect costs. Headache 42:501–509PubMedCrossRef
6.
Zurück zum Zitat Munakata J, Hazard E, Serrano D et al (2009) Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study. Headache 49:498–508PubMedCrossRef Munakata J, Hazard E, Serrano D et al (2009) Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study. Headache 49:498–508PubMedCrossRef
7.
Zurück zum Zitat Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24(1):9–160 Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24(1):9–160
8.
Zurück zum Zitat Mathew NT, Reuveni U, Perez F (1987) Transformed or evolutive migraine. Headache 27:102–106PubMedCrossRef Mathew NT, Reuveni U, Perez F (1987) Transformed or evolutive migraine. Headache 27:102–106PubMedCrossRef
9.
Zurück zum Zitat Mathew NT (1993) Transformed Migraine. Cephalalgia 13:78–83PubMed Mathew NT (1993) Transformed Migraine. Cephalalgia 13:78–83PubMed
10.
Zurück zum Zitat Scher AI, Stewart WF, Ricci JA et al (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106:81–89PubMedCrossRef Scher AI, Stewart WF, Ricci JA et al (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106:81–89PubMedCrossRef
11.
Zurück zum Zitat Bigal ME, Rapoport AM, Sheftell FD et al (2005) Chronic migraine is an earlier stage of transformed migraine in adults. Neurology 65:1556–1561PubMedCrossRef Bigal ME, Rapoport AM, Sheftell FD et al (2005) Chronic migraine is an earlier stage of transformed migraine in adults. Neurology 65:1556–1561PubMedCrossRef
12.
Zurück zum Zitat Peng KP, Fuh JL, Yuan HK et al (2011) New daily persistent headache: should migrainous features be incorporated? Cephalalgia 31:1561–1569PubMedCrossRef Peng KP, Fuh JL, Yuan HK et al (2011) New daily persistent headache: should migrainous features be incorporated? Cephalalgia 31:1561–1569PubMedCrossRef
13.
Zurück zum Zitat Manack A, Buse DC, Serrano D et al (2011) Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology 76:711–718PubMedCrossRef Manack A, Buse DC, Serrano D et al (2011) Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology 76:711–718PubMedCrossRef
14.
15.
Zurück zum Zitat Bono F, Cristiano D, Mastrandrea C et al (2010) The upper limit of normal CSF opening pressure is related to bilateral transverse sinus stenosis in headache sufferers. Cephalalgia 30:145–151PubMedCrossRef Bono F, Cristiano D, Mastrandrea C et al (2010) The upper limit of normal CSF opening pressure is related to bilateral transverse sinus stenosis in headache sufferers. Cephalalgia 30:145–151PubMedCrossRef
16.
Zurück zum Zitat Alper F, Kantarci M, Dane S et al (2004) Importance of anatomical asymmetries of transverse sinuses: an MR enographic study. Cerebrovasc Dis 18(3):236–239PubMedCrossRef Alper F, Kantarci M, Dane S et al (2004) Importance of anatomical asymmetries of transverse sinuses: an MR enographic study. Cerebrovasc Dis 18(3):236–239PubMedCrossRef
17.
Zurück zum Zitat Farb RI, Vanek I, Scott JN, Mikulis DJ, Willinsky RA, Tomlinson G, terBrugge KG (2003) Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60:1418–1424PubMedCrossRef Farb RI, Vanek I, Scott JN, Mikulis DJ, Willinsky RA, Tomlinson G, terBrugge KG (2003) Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60:1418–1424PubMedCrossRef
18.
Zurück zum Zitat Bono F, Salvino D, Tallarico T et al (2010) Abnormal pressure waves in headache sufferers with bilateral transverse sinus stenosis. Cephalalgia 30:1419–1425PubMedCrossRef Bono F, Salvino D, Tallarico T et al (2010) Abnormal pressure waves in headache sufferers with bilateral transverse sinus stenosis. Cephalalgia 30:1419–1425PubMedCrossRef
19.
Zurück zum Zitat De Simone R, Ranieri A, Cardillo G et al (2011) High prevalence of bilateral transverse sinus stenosis-associated IIHWOP in unresponsive chronic headache sufferers: pathogenetic implications in primary headache progression. Cephalalgia 31(6):763–765PubMedCrossRef De Simone R, Ranieri A, Cardillo G et al (2011) High prevalence of bilateral transverse sinus stenosis-associated IIHWOP in unresponsive chronic headache sufferers: pathogenetic implications in primary headache progression. Cephalalgia 31(6):763–765PubMedCrossRef
20.
Zurück zum Zitat De Simone R, Ranieri A, Montella S, Marchese M, Bonavita V (2012) Sinus venous stenosis-associated IIHWOP as a powerful risk-factor for progression and refractoriness of headache. Curr Pain Headache Rep. doi:10.1007/s11916-012-0254-2 PubMed De Simone R, Ranieri A, Montella S, Marchese M, Bonavita V (2012) Sinus venous stenosis-associated IIHWOP as a powerful risk-factor for progression and refractoriness of headache. Curr Pain Headache Rep. doi:10.​1007/​s11916-012-0254-2 PubMed
21.
Zurück zum Zitat De Simone R, Ranieri A, Fiorillo C et al (2010) Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression? Neurol Sci 31:411–415PubMedCrossRef De Simone R, Ranieri A, Fiorillo C et al (2010) Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression? Neurol Sci 31:411–415PubMedCrossRef
22.
Zurück zum Zitat De Simone R, Ranieri A, Bonavita V (2010) Advancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis. Neurol Sci 31(Suppl 1):S33–S39PubMedCrossRef De Simone R, Ranieri A, Bonavita V (2010) Advancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis. Neurol Sci 31(Suppl 1):S33–S39PubMedCrossRef
23.
Zurück zum Zitat Stevens SA, Thakore NJ, Lakin WD, Penar PL, Tranmer BI (2007) A modeling study of idiopathic intracranial hypertension: etiology and diagnosis. Neurol Res 29(8):777–786PubMedCrossRef Stevens SA, Thakore NJ, Lakin WD, Penar PL, Tranmer BI (2007) A modeling study of idiopathic intracranial hypertension: etiology and diagnosis. Neurol Res 29(8):777–786PubMedCrossRef
24.
Zurück zum Zitat Pickard JD, Czosnyka Z, Czosnyka M, Owler B, Higgins JN (2008) Coupling of sagittal sinus pressure and cerebrospinal fluid pressure in idiopathic intracranial hypertension—a preliminary report. Acta Neurochir Suppl 102:283–285PubMedCrossRef Pickard JD, Czosnyka Z, Czosnyka M, Owler B, Higgins JN (2008) Coupling of sagittal sinus pressure and cerebrospinal fluid pressure in idiopathic intracranial hypertension—a preliminary report. Acta Neurochir Suppl 102:283–285PubMedCrossRef
25.
Zurück zum Zitat Higgins JN, Cousins C, Owler BK et al (2003) Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J Neurol Neurosurg Psychiatry 74(12):1662–1666PubMedCrossRef Higgins JN, Cousins C, Owler BK et al (2003) Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J Neurol Neurosurg Psychiatry 74(12):1662–1666PubMedCrossRef
26.
Zurück zum Zitat Bussière M, Falero R, Nicolle D et al (2010) Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension. AJNR 31:645–650PubMedCrossRef Bussière M, Falero R, Nicolle D et al (2010) Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension. AJNR 31:645–650PubMedCrossRef
27.
Zurück zum Zitat Albuquerque FC, Dashti SR, Hu YC et al (2011) Intracranial Venous Sinus Stenting for Benign Intracranial Hypertension: clinical indications, technique and preliminary results. World Neurosurg 75:648–652PubMedCrossRef Albuquerque FC, Dashti SR, Hu YC et al (2011) Intracranial Venous Sinus Stenting for Benign Intracranial Hypertension: clinical indications, technique and preliminary results. World Neurosurg 75:648–652PubMedCrossRef
28.
Zurück zum Zitat Ahmed RM, Wilkinson M, Parker GD et al (2011) Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR 32(8):1408–1414PubMedCrossRef Ahmed RM, Wilkinson M, Parker GD et al (2011) Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR 32(8):1408–1414PubMedCrossRef
29.
Zurück zum Zitat Brazis PW (2008) Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension). Cephalalgia 28:1361–1373PubMedCrossRef Brazis PW (2008) Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension). Cephalalgia 28:1361–1373PubMedCrossRef
30.
Zurück zum Zitat Donnet A, Metellus P, Levrier O et al (2008) Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients. Neurology 70:641–647PubMedCrossRef Donnet A, Metellus P, Levrier O et al (2008) Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients. Neurology 70:641–647PubMedCrossRef
31.
Zurück zum Zitat De Simone R, Marano E, Fiorillo C, Briganti F, Di Salle F, Volpe A, Bonavita V (2005) Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension: pathogenetic implications. Neurol Sci 25:342–344PubMedCrossRef De Simone R, Marano E, Fiorillo C, Briganti F, Di Salle F, Volpe A, Bonavita V (2005) Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension: pathogenetic implications. Neurol Sci 25:342–344PubMedCrossRef
32.
Zurück zum Zitat Scoffings DJ, Pickard JD, Higgins JNP (2007) Resolution of transverse sinus stenoses immediately after CSF withdrawal in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 78:911–912PubMedCrossRef Scoffings DJ, Pickard JD, Higgins JNP (2007) Resolution of transverse sinus stenoses immediately after CSF withdrawal in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 78:911–912PubMedCrossRef
33.
Zurück zum Zitat Lee SW, Gates P, Morris P, Whan A, Riddington L (2009) Idiopathic intracranial hypertension; immediate resolution of venous sinus ‘‘obstruction’’ after reducing cerebrospinal fluid pressure to 10 cmH2O. J Clin Neurosci 16:1690–1692PubMedCrossRef Lee SW, Gates P, Morris P, Whan A, Riddington L (2009) Idiopathic intracranial hypertension; immediate resolution of venous sinus ‘‘obstruction’’ after reducing cerebrospinal fluid pressure to 10 cmH2O. J Clin Neurosci 16:1690–1692PubMedCrossRef
34.
Zurück zum Zitat Bono F, Messina D, Giliberto C et al (2008) Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache. J Neurol 255(6):807–812PubMedCrossRef Bono F, Messina D, Giliberto C et al (2008) Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache. J Neurol 255(6):807–812PubMedCrossRef
35.
Zurück zum Zitat Mathew NT, Ravishankar K, Sanin LC (1996) Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 46:1226–1230PubMedCrossRef Mathew NT, Ravishankar K, Sanin LC (1996) Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 46:1226–1230PubMedCrossRef
36.
Zurück zum Zitat Wang SJ, Silberstein SD, Patterson S et al (1998) Idiopathic intracranial hypertension without papilledema: a case–control study in a headache center. Neurology 51(1):245–249PubMedCrossRef Wang SJ, Silberstein SD, Patterson S et al (1998) Idiopathic intracranial hypertension without papilledema: a case–control study in a headache center. Neurology 51(1):245–249PubMedCrossRef
37.
Zurück zum Zitat Vieira DS, Masruha MR, Gonçalves AL et al (2008) Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine. Cephalalgia 28:609–613PubMedCrossRef Vieira DS, Masruha MR, Gonçalves AL et al (2008) Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine. Cephalalgia 28:609–613PubMedCrossRef
38.
Zurück zum Zitat Bono F, Messina D, Giliberto C et al (2006) Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine. Neurology 67:419–423PubMedCrossRef Bono F, Messina D, Giliberto C et al (2006) Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine. Neurology 67:419–423PubMedCrossRef
39.
Zurück zum Zitat De Simone R, Marano E, Bilo L et al (2006) Idiopathic intracranial hypertension without headache. Cephalalgia 26:1020–1021PubMedCrossRef De Simone R, Marano E, Bilo L et al (2006) Idiopathic intracranial hypertension without headache. Cephalalgia 26:1020–1021PubMedCrossRef
40.
Zurück zum Zitat Silberstein S, Diener HC, Lipton R et al (2008) Epidemiology, risk-factors, and treatment of chronic migraine: a focus on topiramate. Headache 48:1087–1095PubMedCrossRef Silberstein S, Diener HC, Lipton R et al (2008) Epidemiology, risk-factors, and treatment of chronic migraine: a focus on topiramate. Headache 48:1087–1095PubMedCrossRef
41.
Zurück zum Zitat Wall M (2008) Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Neurol Neurosci Rep 8:87–93PubMedCrossRef Wall M (2008) Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Neurol Neurosci Rep 8:87–93PubMedCrossRef
42.
Zurück zum Zitat Marcus DM, Lynn J, Miller JJ et al (2001) Sleep disorders: a risk-factor for pseudotumor cerebri? J Neuroophthalmol 21:121–123PubMedCrossRef Marcus DM, Lynn J, Miller JJ et al (2001) Sleep disorders: a risk-factor for pseudotumor cerebri? J Neuroophthalmol 21:121–123PubMedCrossRef
43.
Zurück zum Zitat Diener HC, Bussone G, Van Oene JC et al (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27:814–823PubMedCrossRef Diener HC, Bussone G, Van Oene JC et al (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27:814–823PubMedCrossRef
44.
Zurück zum Zitat Diener HC, Dodick DW, Goadsby PJ et al (2009) Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 29:1021–1027PubMedCrossRef Diener HC, Dodick DW, Goadsby PJ et al (2009) Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 29:1021–1027PubMedCrossRef
45.
Zurück zum Zitat Dodgson SJ, Shank RP, Maryanoff BE (2000) Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41(1):35–39CrossRef Dodgson SJ, Shank RP, Maryanoff BE (2000) Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41(1):35–39CrossRef
46.
Zurück zum Zitat Johnson LN, Krohel GB, Madsen RW et al (1998) The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 105:2313–2317PubMedCrossRef Johnson LN, Krohel GB, Madsen RW et al (1998) The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 105:2313–2317PubMedCrossRef
47.
Zurück zum Zitat Pagan FL, Restrepo L, Balish M et al (2002) A new drug for an old condition. Headache 42:695–696PubMedCrossRef Pagan FL, Restrepo L, Balish M et al (2002) A new drug for an old condition. Headache 42:695–696PubMedCrossRef
48.
Zurück zum Zitat Palacio E, Rodero L, Pascual J (2004) Topiramate-responsive headache due to idiopathic intracranial hypertension in Behcet syndrome. Headache 44:436–437PubMedCrossRef Palacio E, Rodero L, Pascual J (2004) Topiramate-responsive headache due to idiopathic intracranial hypertension in Behcet syndrome. Headache 44:436–437PubMedCrossRef
49.
Zurück zum Zitat Celebisoy N, Gökçay F, Sirin H et al (2007) Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 116:322–327PubMedCrossRef Celebisoy N, Gökçay F, Sirin H et al (2007) Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 116:322–327PubMedCrossRef
50.
Zurück zum Zitat Curcio M, Salvino D, Quattrone A et al (2011) Topiramate decreases CSF pressure in headache sufferers with idiopathic intracranial hypertension. Proceedings XLII Congress of SIN (Italian Neurological Society). Neurol Sci 32:S9 Curcio M, Salvino D, Quattrone A et al (2011) Topiramate decreases CSF pressure in headache sufferers with idiopathic intracranial hypertension. Proceedings XLII Congress of SIN (Italian Neurological Society). Neurol Sci 32:S9
Metadaten
Titel
Sinus venous stenosis, intracranial hypertension and progression of primary headaches
verfasst von
Roberto De Simone
Angelo Ranieri
Silvana Montella
Mario Marchese
Pasquale Persico
Vincenzo Bonavita
Publikationsdatum
01.05.2012
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe Sonderheft 1/2012
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-012-1037-6

Weitere Artikel der Sonderheft 1/2012

Neurological Sciences 1/2012 Zur Ausgabe

A REDEFINITION OF PRIMARY HEADACHES

A redefinition of primary headache: chronic migraine

MIGRAINE AS A RISK FACTOR

Migraine and cardiovascular diseases

SYMPOSIUM: PERIPHERAL NEUROMODULATION IN CHRONIC MIGRAINE

Peripheral neuromodulation in chronic migraine

MIGRAINE AS A RISK FACTOR

Migraine: risk factor and comorbidity

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.